In chondrocytes, activating FGFR3 mutations induce cell cycle arrest and premature senescence, but drive excessive proliferation in associated tumors, including multiple myeloma and bladder cancer ([83] and reviewed in [84]). The gene discussed is FGFR3; the disease is plasma cell myeloma.